[1] |
World Health Organization. Rabies vaccines: WHO position paper, April 2018-recommendations. Vaccine, 2018; 36, 5500−3. doi: 10.1016/j.vaccine.2018.06.061 |
[2] |
Tao XY, Liu SQ, Zhu WY, et al. Rabies surveillance and control in China over the last twenty years. Biosaf Health, 2021; 3, 142−7. doi: 10.1016/j.bsheal.2020.11.004 |
[3] |
Zhou H, Vong S, Liu K, et al. Human rabies in China, 1960-2014: a descriptive epidemiological study. PLoS Negl Trop Dis, 2016; 10, e0004874. |
[4] |
Lin FT. The protective effect of the large-scale use of phkc rabies vaccine in humans in China. Bull World Health Organ, 1990; 68, 449−54. |
[5] |
Song M, Tang Q, Rayner S, et al. Human rabies surveillance and control in China, 2005-2012. BMC Infect Dis, 2014; 14, 212. doi: 10.1186/1471-2334-14-212 |
[6] |
Wu XF, Hu RL, Zhang YZ, et al. Reemerging rabies and lack of systemic surveillance in People’s Republic of China. Emerg Infect Dis, 2009; 15, 1159−64. doi: 10.3201/eid1508.081426 |
[7] |
Lu XX, Zhu WY, Wu GZ. Rabies virus transmission via solid organs or tissue allotransplantation. Infect Dis Poverty, 2018; 7, 82. doi: 10.1186/s40249-018-0467-7 |
[8] |
Gibson AD, Yale G, Corfmat J, et al. Elimination of human rabies in goa, India through an integrated one health approach. Nat Commun, 2022; 13, 2788. doi: 10.1038/s41467-022-30371-y |
[9] |
Burnett MW. Rabies: 2015 update. J Spec Oper Med, 2015; 15, 105−7. |
[10] |
Yue YJ, Chen QL, Mu D, et al. A descriptive analysis of human rabies in mainland china, 2005-2020. Int J Environ Res Public Health, 2022; 20, 380. |